Linong Ji

68PUBLICATIONS
207CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Medical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Oct 07, 2026
Efficacy and Safety of Chemically Synthesized Semaglutide Injection (HD1916) for the Treatment of Obesity: A Multicenter, Randomized, Phase III Trial.

|Sep 18, 2026
Effectiveness, Safety and Pharmacokinetics of BGM0504, a Dual GLP-1/GIP Receptor Agonist, in Chinese Adults With Overweight or Obesity Without Diabetes: A Phase 2 Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial.

|Aug 05, 2026
Efficacy and Hypoglycaemia Outcomes With Once-Weekly IcoSema Versus Comparators in Individuals With Type 2 Diabetes by Kidney and Liver Function: A Post Hoc Analysis of the COMBINE 1-3 Trials.

|May 31, 2026
Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double-Blind Phase II Trial.

|Apr 13, 2026
Impact of Simulated Risk Factor Management on Cardiovascular Disease and Costs in Type 2 Diabetes Using the ABC Model.

Lee-Ling Lim, Eric S H Lau, Juliana N M Lui

|Mar 10, 2026
Integrated Plasma Proteomics and Functional Analyses Reveal Hepatic CDHR2 as a Potential Therapeutic Target in MASLD.

Yuanping Shi, Qi Huang, Yingning Liu

Pageof 12

Frequent Collaborators

7 joint publications

Marίlia B Gomes

7 joint publications

Kamlesh Khunti

6 joint publications

Hirotaka Watada

5 joint publications

Wei Chen